New HIPAA Rule Scheduled for Publication Today: OK, it's not the new Security Rule revisions we've been expecting, and despite early proclamations that this is a "massive overhaul," it's really not that big a deal, as best I can tell.*
* Here's the caveat: I haven't read the whole thing; I hope to do so over the weekend. But in the meantime, here's my first-blush impression of it (coming soon to a law firm website):
HHS Finalizes
Long-Awaited HIPAA Privacy Rule: Faster Access, Easier Care Coordination, and a
Firm July 2027 Deadline
On November 16, 2026, the U.S. Department of Health and
Human Services Office for Civil Rights (OCR) announced a final rule titled
"HIPAA Privacy Rule: Changes to Support Coordinated Care and Individual
Engagement and Reduce Regulatory Burdens" (RIN 0945-AA00). The final rule
completes a rulemaking process that began with OCR's January 2021 proposal and
adopts much of that proposal, with several notable modifications and omissions
discussed below. The 363-page final rule was posted by OCR for public
inspection on November 16 (Federal Register Document No. 2026-23429) and is
scheduled for publication in the Federal Register on November 19, 2026.
Despite almost six years of anticipation, the final rule is
an incremental adjustment rather than an overhaul. Many of the changes relieve
covered entities of existing obligations or confirm flexibility they already
had, and most of the new requirements will be familiar or easy to meet.
Organizations that already comply with stricter state access laws or federal
interoperability requirements may need to change relatively little. However,
the rule is not merely a paperwork exercise, as cutting by half the medical
records access response period , requiring free electronic access to records in
certain circumstances, and requiring posted fee schedules will require changes
to information release workflows, vendor contracts, and pricing. Also, a covered entity will need to update
its Notice of Privacy Practices, review its fee practices and access
procedures, and review its business associate agreements (especially with
information release vendors) before the compliance date.
•
Federal Register publication: scheduled for November
19, 2026.
•
Effective date: 60 days after publication (January 18,
2027, assuming publication as scheduled).
•
General compliance date: 180 days after the effective
date, or 240 days after publication (July 17, 2027, assuming publication as
scheduled).
•
Business associate agreements: an extended transition
period applies to qualifying existing agreements that must be modified.
Most of the changes concern the individual right of access
under 45 C.F.R. § 164.524, an area that has been a regulatory focus of OCR for
some time.
•
15-day response deadline. Covered entities must
act on access requests as soon as practicable and no later than 15 calendar
days after receipt, cutting the current 30-day period in half. OCR describes 15
days as an outer limit, particularly for electronic copies. For many providers
this changes little: Texas, for example, already requires covered entities using
electronic health records to furnish electronic copies within 15 business days
of a written request (Tex. Health & Safety Code § 181.102), and other state
laws and CMS interoperability requirements impose similar or shorter timelines.
It’s worth noting that Texas entities calibrated to the state deadline will
still need to tighten their processes to meet the shorter 15 calendar day
deadline, and the federal deadline applies to paper records and oral requests
as well. A single extension of up to 30
calendar days remains available with written notice to the individual within
the initial 15-day period. Where another federal or state law requires a
shorter timeframe, that shorter period is deemed practicable. Discussions with
the individual seeking access about the scope or format of a request do not
stop the clock. In addition, Business
Associate Agreements should be modified to incorporate these tighter timelines
for business associates to provide access to records.
•
No unreasonable barriers. Regulated entities may
not impose measures that impede access when a less burdensome method is
practicable, and the rule limits identity verification requirements that
unreasonably burden individuals exercising their access rights. These changes are in line with the 21st
Century Cures Act, which separately prohibits health care providers, health IT
developers, and health information networks from practices likely to interfere
with access to electronic health information unless an exception applies. Conduct that violates HIPAA access rules may
therefore also create information blocking exposure.
•
Personal health applications. The rule adds new
definitions of "electronic health record" and "personal health
application" or “personal health app” and establishes that the right of
access includes obtaining an electronic copy of PHI through a personal health
app when the covered entity can produce it in that form and format. Formats
required by other laws, such as standardized APIs, are deemed readily
producible. App developers selected by the individual are not business
associates, and a covered entity may not deny access to the individual's chosen
app based on concerns about how the app will handle the data after receipt. OCR
distinguishes apps managed primarily for an organization other than the
individual, such as a clinical-trial app run for the trial sponsor, which fall
outside the definition of a personal health app.
•
Directing ePHI to third parties. Consistent with
Ciox Health, LLC v. Azar, the right to direct transmission to a
designated person is limited to electronic copies of PHI in an electronic
health record that is part of the designated record set. "Electronic
health record" is defined broadly to include clinical and billing data
maintained by direct and indirect treatment providers such as laboratories and
radiology practices. Requests must be clear, conspicuous, and specific, and
covered entities may require them in writing. Requests that fall outside this
right, such as a request that paper records be sent to an attorney, should be
handled as disclosures under a valid HIPAA authorization, where the
right-of-access fee limits and timelines do not apply.
•
Fees and transparency. The rule specifies when
electronic PHI must be provided free of charge, including access through a
personal health app and in-person inspection, and requires advance notice of
fees. Covered entities must post estimated fee schedules on their websites for
copies provided under the right of access and under valid authorizations. Because
the posting requirement extends to authorization-based requests, entities that
rely on release-of-information vendors should confirm that vendor pricing is
captured in the posted schedule and that vendor contracts are consistent with
the new fee limits.
•
Summaries. When offering a summary in lieu of
the full record, covered entities must inform individuals that they retain the
right to a complete copy.
The rule amends the definition of "health care
operations" to clarify that health plans may use and disclose PHI for both
population-based and individual-level care coordination and case management. It
also expressly permits covered entities to disclose PHI for individual-level
care coordination and case management to social services agencies,
community-based organizations, home and community-based services (HCBS)
providers, and similar third parties that provide health-related services. This
should ease closed-loop referral programs addressing housing, nutrition, transportation,
and other social needs. The permission has limits. Disclosures must still fit
within treatment or health care operations, and OCR did not finalize the
proposed exception to the minimum necessary standard for individual-level care
coordination, so minimum necessary continues to apply to non-treatment
disclosures. Whether a community partner needs a business associate agreement
depends on the services it performs for the covered entity, not merely on its
receipt of PHI. Also, the permission does not override 42 C.F.R. Part 2 or
state laws requiring consent for sensitive information (for example, in Texas,
mental health and certain other records carry heightened consent requirements),
so layered consent analysis remains necessary.
Direct treatment providers will no longer be required to
make a good-faith effort to obtain a written acknowledgment of receipt of the
Notice of Privacy Practices (NoPP), although the notice must still be provided.
NoPP content requirements are revised to better explain individual rights and
how to exercise them, including available methods of obtaining PHI and
associated fees, and a new right to discuss the notice with a designated
contact person or office. The rule also removes the exception that excluded
inmates of correctional institutions from receiving an NoPP. Most covered entities
should expect to revise and redistribute its NoPP before the compliance date. Entities
should coordinate this revision with other recent NoPP changes. Before eliminating acknowledgment forms,
providers should also confirm that no state law, payer contract, or
accreditation standard independently requires them.
•
Regulated entities may disclose PHI to
Telecommunications Relay Services (TRS) communications assistants for
individuals and workforce members who are deaf, hard of hearing, or deaf-blind,
or who have a speech disability, and TRS providers are excluded from the
definition of business associate.
•
The command-authority permission for mission readiness,
previously limited to the Armed Forces, is expanded to all Uniformed Services,
including the U.S. Public Health Service and NOAA Commissioned Corps.
The rule does not finalize the January 2025 proposed
overhaul of the HIPAA Security Rule. That rulemaking (RIN 0945-AA22) has been
moved to long-term actions, with final action now targeted for July 2027, and
the current Security Rule remains in force. Covered entities and business
associates should continue to prioritize risk analysis and risk management,
which remain the most common findings in OCR Security Rule enforcement. The
2026 Unified Agenda also listed a separate proposed rule on access response
times (RIN 0945-AA28); clients should monitor whether OCR proceeds with that
rulemaking in light of the 15-day deadline adopted here.
The 2021 proposal considered changing the "serious and
imminent threat" standard for disclosures without authorization under 45
C.F.R. § 164.512(j) to a “serious and reasonably foreseeable” standard, and
considered changing the “exercise of professional judgment” standard with a
“good faith belief” standard for disclosures to family members of an individual
suffering from a substance use disorder or serious mental illness. However, OCR ultimately decided not to
implement these changes.
1.
Confirm that access workflows and
release-of-information vendors can meet the 15-calendar day access deadline
(entities calibrated to Texas’s 15-business day standard will need to tighten
timelines), and simplify identity-verification procedures.
2.
Inventory API and patient-portal capabilities and adopt
a policy for personal health app requests that does not deny access based on
downstream app practices.
3.
Review fee practices, including information-release
vendor pricing, identify mandatory no-charge scenarios, and prepare a website
fee schedule for the provision of medical records.
4.
Revise the Notice of Privacy Practices, designate a
contact person or office, and retire acknowledgment-of-receipt processes.
5.
Evaluate care-coordination programs with community
organizations against Part 2 and state law consent requirements if the entity
deals with substance use records or other records with heightened privacy
requirements.
6.
Identify business associate agreements that require
amendment and calendar the transition deadline.
7.
Update policies and procedures and train workforce
members before July 17, 2027 and document the training.